Nyxoah (Nasdaq:NYXH) announced today that it received FDA approval for its Genio neuromodulation device for treating sleep apnea.

NanoVibronix (Nasdaq:NAOV) today announced that it intends to effect a reverse stock split of its common stock.

The FDA approved the protocol update, significantly expanding patient eligibility criteria for enrollment in the study.

Medtronic Diabetes today offered a sneak peek at the new Abbott sensor technology specifically designed for its MiniMed ...

Gentuity announced that it entered into an agreement with GE HealthCare to collaborate on commercial activities for imaging ...

Apreo Health announced today that it closed an oversubscribed $130 million Series B financing round to support its Breathe ...

HistoSonics today announced a management-led majority stake acquisition by a syndicate of private and public investors.

Heartflow has priced its previously announced initial public offering (IPO), with proceeds potentially reaching up to $300 ...

BD (NYSE: BDX) shares ticked up before hours today on third-quarter results that came in ahead of the consensus Wall Street ...

Instylla announced today that it received FDA premarket approval (PMA) for its flagship Embrace hydrogel embolic system (HES) ...

Solventum (NYSE:SOLV) shares rose after hours today on second-quarter results that came in ahead of the consensus forecast.

Zimmer Biomet expects adjusted EPS to range between $8.10 and $8.30 for the full year, rising from a previous range of ...